Ixekizumab Vs. Adalimumab For The Treatment Of Psoriatic Arthritis: 52-Week Efficacy And Safety Outcomes Koyel Chaudhury,Andrew Bradley,Mani Haschemi Nassab,Burkhard Moeller,Klaus P. Machold,Christophe Sapin,Roberto Ranza,Soyi Liu Leage,Peter NashSWISS MEDICAL WEEKLY(2021)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要